Skip to main content
Premium Trial:

Request an Annual Quote

The General Hospital Corporation Awarded US Patent

Premium
The General Hospital Corporation has been awarded US Patent 7,291,454, “Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease.”
 
Inventors listed on the patent are Suzanne de la Monte and Jack Wands.
 

The patent describes transgenic animals and transfected cell lines expressing a protein associated with Alzheimer's disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas, according to its abstract. The invention also describes the use of such transgenic animals and transfected cell lines to screen potential drug candidates for treating or preventing Alzheimer's disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas. The patent relates to new antisense oligonucleotides, ribozymes, triplex-forming DNA, and external guide sequences that can be used to treat or prevent Alzheimer's disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.